TW200724168A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
TW200724168A
TW200724168A TW095110055A TW95110055A TW200724168A TW 200724168 A TW200724168 A TW 200724168A TW 095110055 A TW095110055 A TW 095110055A TW 95110055 A TW95110055 A TW 95110055A TW 200724168 A TW200724168 A TW 200724168A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical compositions
pharmaceutical composition
granulates
riboguranosyl
cytidine
Prior art date
Application number
TW095110055A
Other languages
English (en)
Inventor
Katja Jores
Andreas Meyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200724168A publication Critical patent/TW200724168A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
TW095110055A 2005-03-24 2006-03-23 Pharmaceutical compositions TW200724168A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66473305P 2005-03-24 2005-03-24

Publications (1)

Publication Number Publication Date
TW200724168A true TW200724168A (en) 2007-07-01

Family

ID=37024189

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095110055A TW200724168A (en) 2005-03-24 2006-03-23 Pharmaceutical compositions

Country Status (15)

Country Link
US (1) US20080207533A1 (zh)
EP (1) EP1865926A2 (zh)
JP (1) JP2008546635A (zh)
KR (1) KR20080011278A (zh)
CN (1) CN101146519A (zh)
AR (1) AR052952A1 (zh)
AU (1) AU2006226521A1 (zh)
BR (1) BRPI0609442A2 (zh)
CA (1) CA2602000A1 (zh)
GT (1) GT200600119A (zh)
MX (1) MX2007011704A (zh)
PE (1) PE20061352A1 (zh)
RU (1) RU2007139105A (zh)
TW (1) TW200724168A (zh)
WO (1) WO2006100087A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CA2410579C (en) 2000-05-26 2010-04-20 Jean-Pierre Sommadossi Methods and compositions for treating flaviviruses and pestiviruses
MXPA05005192A (es) 2002-11-15 2005-09-08 Idenix Cayman Ltd Nucleosidos ramificados en la posicion 2' y mutacion de flaviviridae.
JP5527921B2 (ja) * 2006-12-22 2014-06-25 エスエス製薬株式会社 苦味を隠蔽した経口固形組成物
MX362994B (es) * 2013-07-31 2019-03-01 Chugai Pharmaceutical Co Ltd Preparacion farmaceutica que comprende un derivado de aminopirazol.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533824A (ja) * 2002-06-28 2005-11-10 イデニクス(ケイマン)リミテツド フラビウイルス科感染の治療のための2’−c−メチル−3’−o−l−バリンエステルリボフラノシルシチジン

Also Published As

Publication number Publication date
WO2006100087A2 (en) 2006-09-28
MX2007011704A (es) 2007-11-15
AR052952A1 (es) 2007-04-11
BRPI0609442A2 (pt) 2010-04-06
GT200600119A (es) 2006-10-25
CN101146519A (zh) 2008-03-19
WO2006100087A3 (en) 2007-02-15
CA2602000A1 (en) 2006-09-28
EP1865926A2 (en) 2007-12-19
AU2006226521A1 (en) 2006-09-28
RU2007139105A (ru) 2009-04-27
JP2008546635A (ja) 2008-12-25
KR20080011278A (ko) 2008-02-01
US20080207533A1 (en) 2008-08-28
PE20061352A1 (es) 2007-01-11

Similar Documents

Publication Publication Date Title
WO2008005542A3 (en) Antiviral phosphinate compounds
HK1133257A1 (zh)
TW200728307A (en) Novel spirochromanone derivatives
MX2009003184A (es) Composiciones farmaceuticas que comprenden nilotinib o su sal.
TW200612958A (en) Substituted imidazole derivatives
TW200740758A (en) Benzoquinazoline derivatives
UA94052C2 (uk) Похідні піридазину
TW200744588A (en) Pharmaceutical composition for external use
WO2007084728A3 (en) 2-imino-benzimidazoles
BRPI0716598A2 (pt) Derivados de (hetero) arilsulfonamida de n-biarila úteis no tratamento de doenças medidas por interações de linfócitos
MX2009005691A (es) Inhibidores de la enzima de diacilglicerol o-acilotransferasa tipo i.
MX2009003081A (es) Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
WO2007002559A8 (en) Pyrazole based lxr modulators
ZA200801172B (en) Caspase inhibitor prodrugs
AU2008255733A8 (en) Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
WO2007005941A3 (en) Liver targeted conjugates
MY147188A (en) Substituted imidazole compounds as ksp inhibitors
TN2009000287A1 (en) Cyclized derivatives as eg-5inhibitors
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
TW200724168A (en) Pharmaceutical compositions
IL192190A0 (en) Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
MX2007011826A (es) Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.
MX2010001243A (es) Composicion anti-inflamatoria.
WO2006079077A3 (en) Use of diltiazem or analogs thereof as modulators of ghrelin receptor
GEP20084470B (en) New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them